Efficacy of the holy basil in the treatment of oral submucous fibrosis: a systematic review and meta-analysis

INTRODUCTION. The review aimed to evaluate the therapeutic efficacy of holy basil (ocimum sanctum) in managing oral submucous fibrosis (OSMF), focusing on its impact on clinical symptoms such as burning sensation, mouth opening, tongue protrusion, cheek flexibility, blanching, and fibrosis.

MATERIALS AND METHODS. A comprehensive search was conducted across PubMed-Medline, Scopus, Embase, Cochrane Library and Google Scholar from the earliest available date upto 5 th April, 2025. Studies included were randomized controlled trials (RCTs) and observational studies involving patients diagnosed with OSMF, assessing the efficacy of holy basil in any formulation (such as extract or oil) on clinical symptoms. Both Two reviewers independently performed data extraction and quality assessment using the Cochrane RoB 2.0 and ROBINS-I tools. Where appropriate, a metaanalysis (MA) was performed, where summarized raw mean (MRAW) standardized mean differences (SMDs) were calculated.

RESULTS. A total of 7 studies met the inclusion criteria, comprising 5 observational and 2 experimental studies conducted in India between 2017 and 2023. The MA demonstrated significant improvements in maximal mouth opening with MRAW = 36.14 mm; 95% confidence interval [CI]: 22.3–49.98) and reduction in burning sensation (SMD = 2.6; 95% CI: 1.94–3.25) in patients receiving holy basil-based treatments. Substantial heterogeneity was noted for mouth opening outcomes (I² = 96%), whereas the results for burning sensation were relatively consistent across studies (I² < 50%). Secondary outcomes, such as cheek flexibility, were reported in only one study, restricting broader generalization.

CONCLUSIONS. The findings suggest that Holy Basil, administered in various formulations, shows promising potential in improving key clinical symptoms such as maximal mouth opening, burning sensation, and tongue protrusion.

1. Warnakulasuriya S., Kujan O., Aguirre-Urizar J.M., Bagan J.V., González-Moles M.Á., Kerr A.R. et al. Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2021;27(8):1862–1880. https://doi.org/10.1111/odi.13704

2. Shen Y.W., Shih Y.H., Fuh L.J., Shieh T.M. Oral submucous fibrosis: a review on biomarkers, pathogenic mechanisms, and treatments. Int J Mol Sci. 20200;21(19):7231. https://doi.org/10.3390/ijms21197231

3. Tang J., Liu J., Zhou Z., Cui X., Tu H., Jia J. et al. Oral submucous fibrosis: pathogenesis and therapeutic approaches. Int J Oral Sci. 2025;17(1):8. https://doi.org/10.1038/s41368-024-00344-6

4. Gilbertson E.O., Spellman M.C., Piacquadio D.J., Mulford M.I. Super potent topical corticosteroid use associated with adrenal suppression: clinical considerations. J Am Acad Dermatol. 1998;38(2 Pt 2):318–321. https://doi.org/10.1016/s0190-9622(98)70573-0

5. Chhabra A.K., Sune R., Reche A. Oral submucous fibrosis: A review of the current concepts in management. Cureus. 2023;15(10):e47259. https://doi.org/10.7759/cureus.47259

6. Kholakiya Y., Jose A., Rawat A., Nagori S.A., Jacob S., Roychoudhury A. Surgical management of oral submucous fibrosis with “Seagull-nasolabial flap” combined with short-term oral pentoxifylline for preventing relapse. J Stomatol Oral Maxillofac Surg. 2020;121(5):512–516. https://doi.org/10.1016/j.jormas.2019.12.015

7. Xu H., Lyu F.-Y., Song J.-Y., Xu Y.-M., Jiang E.-H., Shang Z.-J. et al. Research achievements of oral submucous fibrosis: Progress and prospect. BioMed Res Int. 2021;2021:6631856. https://doi.org/10.1155/2021/6631856

8. Krishnaiahpendem, Katiyar R., Nair P.P., Shiva Kumar G.C., Sathe R., Raj A. Comparison of effectiveness of Spirulina and Lycopene as an adjuvant to corticosteroid (Triamcinolone acetonide) injection in the management of oral submucous fibrosis (OSMF) – Randomized control trial. J Adv Med Dent Scie Res. 2024;12(1):47–50. Available at: https://www.jamdsr.com/uploadfiles/9vol12issue1pp47-5020240126051554.pdf (accessed: 02.05.2025).

9. Sambandam V., Neelakantan P. Steroids in dentistry – A review. Int J Pharm Sci Rev Res. 2013;22(2):240–245. Available at: https://www.globalresearchonline.net/journalcontents/v22-2/44.pdf (accessed: 02.05.2025).

10. Zare P., Saeedi M., Akbari J., Morteza-Semnani K. A review on herbal oral care products. J Mazandaran Univ Med Sci. 2017;26(144):394–410. Available at: http://jmums.mazums.ac.ir/article-1-9287-en.html (accessed: 02.05.2025).

11. Chen X., Xie H., Guo J. Drug treatment for oral submucous fibrosis: an update. BMC Oral Health. 2023;23(1):748. https://doi.org/10.1186/s12903-023-03488-9

12. Barrera S.D., Cepeda L.J.B., Báez D.A.D., Kwon J., Siddiq A., Parra J.E.C. et al. Herbal extracts in orofacial pain: a systematic review and direct and indirect meta-analysis. Sci Rep. 2024;14(1):29656. https://doi.org/10.1038/s41598-024-77796-7

13. Mehta V., Mathur A., Tripathy S., Sa R., Sharma T. Effectiveness of herbal oral care products in reducing dental plaque and gingivitis: an overview of systematic reviews. Can J Dent Hyg. 2024;58(2):120–134. Available at: https://files.cdha.ca/profession/journal/2818.pdf (accessed: 02.05.2025).

14. Yuwanati M., Ramadoss R., Kudo Y., Ramani P., Senthil Murugan M. Prevalence of oral submucous fibrosis among areca nut chewers: A systematic review and meta-analysis. Oral Dis. 2023;29(5):1920–1926. https://doi.org/10.1111/odi.14235

15. Mello F.W., Miguel A.F.P., Dutra K.L., Porporatti A.L., Warnakulasuriya S., Guerra E.N.S., Rivero E.R.C. Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis. J Oral Pathol Med. 2018;47(7):633–640. https://doi.org/10.1111/jop.12726

16. Saalim M., Sansare K., Karjodkar F.R., Johaley S., Ali I.K., Sharma S.R. et al. The prevalence of oral squamous cell carcinoma with oral submucous fibrosis. J Cancer Res Ther. 2021;17(6):1510–1514. https://doi.org/10.4103/jcrt.JCRT_719_19

17. Mehta V., Shetiya S.H., Kakodkar P., Janakiram C., Rizwan S.A. Efficacy of herbal dentifrice on the prevention of plaque and gingivitis as compared to conventional dentifrice: A systematic review and meta-analysis. J Indian Soc Periodontol. 2018;22(5):379–389. https://doi.org/10.4103/jisp.jisp_100_18

18. Sanjay C.J., Shastry S.P., Karthikeya P., Nagabhushana D., Kumar N., Sharma S. Herbal therapy in oral submucous fibrosis: A short review. Indian J Forensic Med Toxicol. 2021;15(3):509–513.

19. Shao Y., Miao J., Wang Y. Curcumin in the treatment of oral submucous fibrosis: a systematic review and meta-analysis of randomized controlled trials. Int J Oral Maxillofac Surg. 2024;53(3):239–250. https://doi.org/10.1016/j.ijom.2023.11.005

20. Al-Maweri S.A., Ashraf S., Lingam A.S., Alqutaibi A., Abdulrab S., Alaizari N., Halboub E. Aloe vera in treatment of oral submucous fibrosis: A systematic review and meta-analysis. J Oral Pathol Med. 2019;48(2):99–107. https://doi.org/10.1111/jop.12789

21. Gupta N., Kalaskar A., Kalaskar R. Efficacy of lycopene in management of Oral Submucous Fibrosis – A systematic review and meta-analysis. J Oral Biol Craniofac Res. 2020;10(4):690–697. https://doi.org/10.1016/j.jobcr.2020.09.004

22. Xie H., Guo J., Tan B., Wu H. Efficacy of Salvia miltiorrhiza injection combined with steroids in the treatment of oral submucous fibrosis: A meta-analysis of randomized controlled trials. Medicine. 2019;98(27):e16339. https://doi.org/10.1097/MD.0000000000016339

23. Mathur A., Gopalakrishnan D., Mehta V., Rizwan S.A., Shetiya S.H., Bagwe S. Efficacy of green tea-based mouthwashes on dental plaque and gingival inflammation: A systematic review and meta-analysis. Indian J Dent Res. 2018;29(2):225–232. https://doi.org/10.4103/ijdr.IJDR_493_17

24. Pai K.R., Pallavi L.K., Bhat S.S., Hegde S.K. Evaluation of antimicrobial activity of aqueous extract of “Ocimum Sanctum-Queen of Herb” on dental caries microorganisms: An in vitro study. Int J Clin Pediatr Dent. 2022;15(Suppl. 2):S176–S179. https://doi.org/10.5005/jp-journals-10005-2147

25. Gandhalikar S., Chauhan N., Gupta A., Kapadia J., Jain M., Kaur A. A review on herbal extracts in dentistry: Current scenario and future trends. South Asian Res J Oral Dent Sci. 2022;4(2):15–19. https://doi.org/10.36346/sarjods.2022.v04i02.003

26. Suthar V. Benefit of tulsi for general and dental medicine. J Pharm Res Innov. 2022;2(2):29–35. https://doi.org/10.36647/JPRI/02.02.A006

27. Dubey P.S., Mittal N. Review on oral submucous fibrosis: New theoretical approaches with etiopathogenesis and ayurvedic treatments. Int J Res Anal Rev. 2020;7(2):378–392. Available at: https://papers.ssrn.com/abstract=3649317 (accessed: 02.05.2025).

28. Srivastava A., Agarwal R., Chaturvedi T.P., Chandra A., Singh O.P. Clinical evaluation of the role of tulsi and turmeric in the management of oral submucous fibrosis: A pilot, prospective observational study. J Ayurveda Integr Med. 2015;6(1):45–49. https://doi.org/10.4103/0975-9476.146563

29. Mobeen S., Sv R., Jd S., Prakash R., D S., Swayampakula H. et al. A novel herbal paste formulation of turmeric, tulsi, and honey for the treatment of oral submucous fibrosis. Cureus. 2023;15(10):e46608. https://doi.org/10.7759/cureus.46608

30. Ghone U., Sarode G., Sarode S. Natural Compounds in the Treatment of Oral Submucous Fibrosis. In: Chauhan D.N., Singh P.R., Chauhan N.S., Shah K. (eds). Pharmacological Studies in Natural Oral Care. Scrivener Publishing LLC; 2023. Chapter 10, pp. 183–196. https://doi.org/10.1002/9781394167197.ch10

31. Vamshi N.S., Rakesh N., Sharma G., Dixit C., Gautam N., Gautam N.K. Pharmacological and Non Pharmacological Management of OSMF. Book Rivers; 2023. 104 p.

32. Singh A.K., Sawarkar G.R., Deshpande A.M., Gudadhe R.R., Balkhande S.B. Evaluation of efficacy of tulsiturmeric oil pulling in oral submucous fibrosis (Vata Pitta Dominant Tridosaja Sarvasara Mukharoga): A narrative review. J Clin Diagn Res. 2024;18(7):ZE01–ZE05. https://doi.org/10.7860/JCDR/2024/68498.19639

33. Choi S.H. WHO traditional medicine strategy and activities. “Standardization with evidence-based approaches”. J Acupunct Meridian Stud. 2008;1(2):153–154. https://doi.org/10.1016/S2005-2901(09)60037-6

34. NCI Dictionary of Cancer Terms. Available at: https://web.archive.org/web/20180914111122/https://www.cancer.gov/publications/dictionaries/cancer-terms (accessed: 15.05.2025).

35. Boyd S.B., Walters A.S. Effectiveness of treatment apnea-hypopnea index: a mathematical estimate of the true apnea-hypopnea index in the home setting. J Oral Maxillofac Surg. 2013;71(2):351–357. https://doi.org/10.1016/j.joms.2012.05.009

36. Siddiqui H.K., Khan F.R., Sadiq A., Hashmi U., Qaiser Z. Predictors of the severity of oral submucous fibrosis among gutka consumers: a regression analysis. Br J Oral Maxillofac Surg. 2021;59(6):690–694. https://doi.org/10.1016/j.bjoms.2020.09.005

37. Sterne J.A.C., Savović J., Page M.J., Elbers R.G., Blencowe N.S., Boutron I. et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. https://doi.org/10.1136/bmj.l4898

38. Sterne J.A., Hernán M.A., Reeves B.C., Savović J., Berkman N.D., Viswanathan M. et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. https://doi.org/10.1136/bmj.i4919

39. Madhulatha G., Vijayalaxmi N., Harshavardhan T. Tulasi a magical herb and a boon for management of oral submucous fibrosis: a clinical study. Int J Res Med Sci. 2017;5(11):4719–4723. https://doi.org/10.18203/2320-6012.ijrms20174644

40. Virani D., Dangore S., Bhowate R. Assessment of utility of Tulsi and Turmeric in treatment of oral submucous fibrosis: A clinical study. Int J Dent Res. 2018;3(1):30–33. https://doi.org/10.31254/dentistry.2018.3108

41. Khabiya P., Maity P., Halli R., Pawar S., Hebbale M. Efficacy of Turmeric and Tulsi in management of oral submucous fibrosis. J Dent Oro-Facial Res. 2019;15(2):31–37.

42. Rizvi D., Abidi A., Faiz S.M., Hasan R., Thadani A. Efficacy of curcumin gel and tulsi gel in oral submucous fibrosis. Natl J Physiol Pharm Pharmacol. 2019;9(4):343–348. https://doi.org/10.5455/njppp.2019.9.0203416022019

43. Thomas T., Hegde S. Comparative study on efficacy of tulsi and oxitard in the management of oral submucous fibrosis (OSMF). World J Pharm Res. 2024;13(1):1280–1292. Available at: https://www.wjpr.net/abstract_file/24058 (accessed: 15.05.2025).

44. Biswas D., Naik Z., Kumar S.L., Patil N., Bagewadi A. Efficacy of topical tulsi (Ocimum sanctum) paste for the management of oral submucous fibrosis – A clinical study. Indian J Dent Res. 2022;33(2):146–151. https://doi.org/10.4103/ijdr.IJDR_929_20

45. Dalai R.P., Abdulcader Riyaz S.M., Awinashe M., Almutairy M., Sidhu R., Amlutairi F.J., Ramaiah V.V. Assessment of aloe vera and tulsi’s effectiveness in treating oral submucous fibrosis. J Pharm Bioallied Sci. 2023;15(Suppl. 2):S1136–S1138. https://doi.org/10.4103/jpbs.jpbs_190_23

46. Ara N., Sultana T., Alwal R., Bolleddu R., Venkatesh S. A strategy to enhance bioavailability of drug candidates: natural bioenhancers. SunText Rev Pharm Sci. 2021;2(1):108. https://doi.org/10.51737/2766-5232.2021.008

47. Bagwe S., Mehta V., Mathur A., Kumbhalwar A., Bhati A. Role of various pharmacologic agents in alveolar bone regeneration: A review. Natl J Maxillofac Surg. 2023;14(2):190–197. https://doi.org/10.4103/njms.njms_436_21